--- title: "BioNTech Appoints Kylie Jimenez as Chief People Officer" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/273992891.md" datetime: "2026-01-28T13:00:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273992891.md) - [en](https://longbridge.com/en/news/273992891.md) - [zh-HK](https://longbridge.com/zh-HK/news/273992891.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273992891.md) | [English](https://longbridge.com/en/news/273992891.md) # BioNTech Appoints Kylie Jimenez as Chief People Officer BioNTech SE has appointed Kylie Jimenez as Chief People Officer and member of the Management Board, effective March 1, 2026. Jimenez, who brings over 20 years of international HR experience, will lead BioNTech’s people strategy and workforce initiatives from the company’s headquarters in Mainz, Germany. She joins BioNTech from Georg Fischer, where she served as global Chief Human Resources Officer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001161633-en) on January 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) ### 相關股票 - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [BioNTech SE (BNTX.US)](https://longbridge.com/zh-HK/quote/BNTX.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) ## 相關資訊與研究 - [BioNTech's founding couple Sahin, Tuereci to leave to set up new venture](https://longbridge.com/zh-HK/news/278538947.md) - [BioNTech Co-Founders to Launch Independent mRNA Venture as Company Refocuses on Late-Stage Pipeline](https://longbridge.com/zh-HK/news/278540977.md) - [Deutsche Bank Keeps Their Buy Rating on BioNTech SE (BNTX)](https://longbridge.com/zh-HK/news/278570303.md) - [Altimmune Details Pemvidutide MASH Path: Breakthrough Therapy, FDA Feedback, Phase 3 Next Up](https://longbridge.com/zh-HK/news/278790627.md) - [BUZZ-MiNK Therapeutics rises as it wins funding for child cancer cell therapy](https://longbridge.com/zh-HK/news/278530484.md)